The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSCPA.L Regulatory News (SCPA)

  • There is currently no data for SCPA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.5 (EPT/NON-RI) Scapa Group Plc

13 Apr 2021 10:00

RNS Number : 2938V
Jefferies International Limited.
13 April 2021
 

FORM 8.5 (EPT/NON-RI)

 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN

EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI") STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Jefferies International Limited

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Scapa Group plc

(c) Name of the party to the offer with which exempt principal trader is connected:

Scapa Group plc

(d) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

12th April 2021

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

 

5p ordinary

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

500,000

0.266

(2) Cash-settled derivatives:

 

500,000

0.266

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

TOTAL:

500,000

0.266

500,000

0.266

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

5p ordinary

 

 

Purchase

 

 

724,000

 

 

212.6460 GBX

 

 

212.6460 GBX

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

5p ordinary

 

Swap

 

Closing a long position

 

 

724,000

 

214.5000 GBX

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

 

 

Date of disclosure:

13th April 2021

Contact name:

Zara Watters

Telephone number:

020 7029 8661

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FEOKXLBFFZLBBBB
Date   Source Headline
19th May 20201:35 pmRNSStandard form for notification of major holdings
14th May 202012:06 pmRNSResults of Placing
14th May 20207:00 amRNSTrading Update, Financing and Proposed Placing
7th May 20207:00 amRNSUpdate on Notice of Full Year Results
4th May 20207:00 amRNSDirectorate Changes
30th Apr 202010:20 amRNSTotal Voting Rights
27th Apr 20203:03 pmRNSHolding(s) in Company
16th Apr 20209:33 amRNSAdditional Listing of Shares
31st Mar 202010:00 amRNSTotal Voting Rights
27th Mar 20207:00 amRNSCOVID-19 UPDATE
20th Mar 202012:07 pmRNSSecond Price Monitoring Extn
20th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 202010:00 amRNSBlock Listing Application
3rd Mar 202012:07 pmRNSSecond Price Monitoring Extn
3rd Mar 202012:02 pmRNSPrice Monitoring Extension
2nd Mar 20209:41 amRNSTotal Voting Rights
28th Feb 20207:00 amRNSScapa Group Directorate Change
27th Feb 202011:44 amRNSHolding(s) in Company
14th Feb 20209:00 amRNSHolding(s) in Company
12th Feb 202010:00 amRNSHolding(s) in Company
12th Feb 20207:00 amRNSTrading Update
31st Jan 202010:15 amRNSTotal Voting Rights
24th Jan 202010:45 amRNSBlock listing six monthly return
20th Jan 20202:38 pmRNSDirectorate Appointment
2nd Jan 20202:06 pmRNSTotal Voting Rights
29th Nov 201911:08 amRNSTotal Voting Rights
28th Nov 20192:41 pmRNSStandard form for notification of major holdings
22nd Nov 20191:17 pmRNSCorrection - Holding(s) in Company
21st Nov 201910:14 amRNSHolding(s) in Company
19th Nov 20197:00 amRNSScapa Group: Interim Results
12th Nov 20194:16 pmRNSStandard form for notification of major holdings
31st Oct 20199:58 amRNSTotal Voting Rights
25th Oct 20197:00 amRNSNotice of Results
9th Oct 20197:00 amRNSPeriod end update
30th Sep 20199:20 amRNSTotal Voting Rights
13th Sep 201911:19 amRNSDirector/PDMR Shareholding
30th Aug 20199:22 amRNSTotal Voting Rights
7th Aug 20194:29 pmRNSAdditional Listing
31st Jul 20193:29 pmRNSTotal Voting Rights
25th Jul 201910:30 amRNSBlock listing Interim Review
23rd Jul 20194:39 pmRNSResult of AGM
23rd Jul 20197:00 amRNSAGM Statement
11th Jul 20197:00 amRNSScapa commences legal action against ConvaTec
9th Jul 201910:38 amRNSAdditional Listing
2nd Jul 20191:37 pmRNSTotal Voting Rights
28th Jun 20193:36 pmRNSDirectorate Change
21st Jun 20192:05 pmRNSDirector/PDMR Shareholding
19th Jun 201912:49 pmRNSHolding(s) in Company
18th Jun 20198:46 amRNSDirector/PDMR Shareholding
14th Jun 20199:36 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.